But injectable B12 might be needed for severe cases or when absorption is a problem
The Geography of the GLP-1 Divide The states bearing the nation's heaviest burden of obesity are also the ones where GLP medications consume the largest share of income
Retatrutide is a triple-agonist peptide targeting GLP-1 + GIP + glucagon receptors simultaneously the most pronounced weight-loss data from any metabolic peptide studied to date
Instead, the FDA cited 'deficiencies in the manufacturing and chemistry documentation (CMC).' This means the issues are related to the paperwork and processes around how the drug is made, rather than how well it works or its side effects in patients
Finally, in some included studies, the primary outcome was not aiming at the weight change after treatment withdrawal, so the information was incomplete
Raised in Tampa, Florida, Dr